AIM: To assess corticotropin-releasing factor receptor 2 (CRF2) expression in the colon of healthy subjects and patients with ulcerative colitis (UC). METHODS: We examined CRF2 gene and protein expression in the distal/sigmoid colonic mucosal biopsies from healthy subjects and patients with UC (active or disease in remission), human immunodeficiency virus (HIV) and functional bowel disease (FBD) by reverse transcription-polymerase chain reaction and immunofluorescence. RESULTS: Gene expression of CRF2 was demonstrated in the normal human colonic biopsies, but not in the human colorectal adenocarcinoma cell line Caco2. Receptor protein localization showed immunoreactive CRF2 receptors in the lamina propria and in the epithelial cells of the distal/sigmoid biopsy samples. Interestingly, CRF2 immunoreactivity was no longer observed in epithelial cells of patients with mild-moderately active UC and disease in remission, while receptor protein expression did not change in the lamina propria. No differences in CRF2 expression profile were observed in distal/sigmoid intestinal biopsies from HIV infection and FBD patients, showing no signs of inflammation. CONCLUSION: The down-regulation of the CRF2 receptor in the distal/sigmoid biopsies of UC patients is indicative of change in CRF2 signalling associated with the process of inflammation.
AIM: To assess corticotropin-releasing factor receptor 2 (CRF2) expression in the colon of healthy subjects and patients with ulcerative colitis (UC). METHODS: We examined CRF2 gene and protein expression in the distal/sigmoid colonic mucosal biopsies from healthy subjects and patients with UC (active or disease in remission), humanimmunodeficiency virus (HIV) and functional bowel disease (FBD) by reverse transcription-polymerase chain reaction and immunofluorescence. RESULTS: Gene expression of CRF2 was demonstrated in the normal human colonic biopsies, but not in the humancolorectal adenocarcinoma cell line Caco2. Receptor protein localization showed immunoreactive CRF2 receptors in the lamina propria and in the epithelial cells of the distal/sigmoid biopsy samples. Interestingly, CRF2 immunoreactivity was no longer observed in epithelial cells of patients with mild-moderately active UC and disease in remission, while receptor protein expression did not change in the lamina propria. No differences in CRF2 expression profile were observed in distal/sigmoid intestinal biopsies from HIV infection and FBDpatients, showing no signs of inflammation. CONCLUSION: The down-regulation of the CRF2 receptor in the distal/sigmoid biopsies of UC patients is indicative of change in CRF2 signalling associated with the process of inflammation.
Authors: Richard L Hauger; Dimitri E Grigoriadis; Mary F Dallman; Paul M Plotsky; Wylie W Vale; Frank M Dautzenberg Journal: Pharmacol Rev Date: 2003-03 Impact factor: 25.468
Authors: T W Lovenberg; C W Liaw; D E Grigoriadis; W Clevenger; D T Chalmers; E B De Souza; T Oltersdorf Journal: Proc Natl Acad Sci U S A Date: 1995-01-31 Impact factor: 11.205
Authors: M Kohno; Y Kawahito; Y Tsubouchi; A Hashiramoto; R Yamada; K I Inoue; Y Kusaka; T Kubo; I J Elenkov; G P Chrousos; M Kondo; H Sano Journal: J Clin Endocrinol Metab Date: 2001-09 Impact factor: 5.958
Authors: E Chatzaki; I Charalampopoulos; C Leontidis; I A Mouzas; M Tzardi; C Tsatsanis; A N Margioris; A Gravanis Journal: J Clin Endocrinol Metab Date: 2003-01 Impact factor: 5.958
Authors: Jen Chang; Julia J Hoy; Prema S Idumalla; Matthew S Clifton; Norman C Pecoraro; Aditi Bhargava Journal: Peptides Date: 2007-05-21 Impact factor: 3.750
Authors: P E Boyer; S D'Costa; L L Edwards; M Milloway; E Susick; L B Borst; S Thakur; J M Campbell; J D Crenshaw; J Polo; A J Moeser Journal: Br J Nutr Date: 2015-02-11 Impact factor: 3.718
Authors: Ann T Hanna-Mitchell; Amanda Wolf-Johnston; James R Roppolo; Tony C A Buffington; Lori A Birder Journal: J Endocrinol Date: 2014-05-14 Impact factor: 4.286